Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Mangiola

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Frontiers in Transplantation|April 17, 2026
Exploratory biomarkers for acute rejection in vascularized composite allotransplantationDominika Pullmann, William J Rifkin, Haruyuki Hirayama, et al.
Clinical Transplantation|June 11, 2022
One-year immunologic outcomes of lung transplantation utilizing hepatitis C-viremic donorsTyler C Lewis, Melissa Lesko, Darya Rudym, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 31, 2021
Impact of carfilzomib-based desensitization on heart transplantation of sensitized candidatesRoy Sriwattanakomen, Qingyong Xu, Moses Demehin, et al.
Transplantation Direct|January 13, 2025
Clinical Outcomes and Donor-specific Antibody Rebound 5 y After Kidney Transplant Enabled by Imlifidase DesensitizationIan S Jaffe, Anna Runström, Vasishta S Tatapudi, et al.
Plastic and Reconstructive Surgery. Global Open|July 14, 2026
Rituximab-based Induction in Vascularized Composite Allotransplantation: Prolonged Rejection-free Survival and the Role of Donor-specific AntibodiesAlexis K Gursky, Sachin R Chinta, Hailey P Wyatt, et al.
Haematologica|August 26, 2003
Expression of CD10 by B-chronic lymphocytic leukemia cells undergoing apoptosis in vivo and in vitroFortunato Morabito, Massimo Mangiola, Davide Rapezzi, et al.
Transplantation|December 22, 2017
Immune Responses of HLA Highly Sensitized and Nonsensitized Patients to Genetically Engineered Pig CellsZhongqiang Zhang, Hidetaka Hara, Cassandra Long, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 17, 2017
Short-term adverse effects of early subclinical allograft inflammation in kidney transplant recipients with a rapid steroid withdrawal protocolRajil Mehta, Sushma Bhusal, Parmjeet Randhawa, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 28, 2020
Donor-specific antibody characteristics, including persistence and complement-binding capacity, increase risk for chronic lung allograft dysfunctionCarlo J Iasella, Christopher R Ensor, Marilyn Marrari, et al.
Nature Communications|July 1, 2025
Impact of HLA evolutionary divergence and donor-recipient molecular mismatches on antibody-mediated rejection of kidney allograftsZeynep Demir, Marc Raynaud, Gillian Divard, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Frontiers in Transplantation|April 17, 2026
Exploratory biomarkers for acute rejection in vascularized composite allotransplantationDominika Pullmann, William J Rifkin, Haruyuki Hirayama, et al.
Clinical Transplantation|June 11, 2022
One-year immunologic outcomes of lung transplantation utilizing hepatitis C-viremic donorsTyler C Lewis, Melissa Lesko, Darya Rudym, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 31, 2021
Impact of carfilzomib-based desensitization on heart transplantation of sensitized candidatesRoy Sriwattanakomen, Qingyong Xu, Moses Demehin, et al.
Transplantation Direct|January 13, 2025
Clinical Outcomes and Donor-specific Antibody Rebound 5 y After Kidney Transplant Enabled by Imlifidase DesensitizationIan S Jaffe, Anna Runström, Vasishta S Tatapudi, et al.
Plastic and Reconstructive Surgery. Global Open|July 14, 2026
Rituximab-based Induction in Vascularized Composite Allotransplantation: Prolonged Rejection-free Survival and the Role of Donor-specific AntibodiesAlexis K Gursky, Sachin R Chinta, Hailey P Wyatt, et al.
Haematologica|August 26, 2003
Expression of CD10 by B-chronic lymphocytic leukemia cells undergoing apoptosis in vivo and in vitroFortunato Morabito, Massimo Mangiola, Davide Rapezzi, et al.
Transplantation|December 22, 2017
Immune Responses of HLA Highly Sensitized and Nonsensitized Patients to Genetically Engineered Pig CellsZhongqiang Zhang, Hidetaka Hara, Cassandra Long, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 17, 2017
Short-term adverse effects of early subclinical allograft inflammation in kidney transplant recipients with a rapid steroid withdrawal protocolRajil Mehta, Sushma Bhusal, Parmjeet Randhawa, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 28, 2020
Donor-specific antibody characteristics, including persistence and complement-binding capacity, increase risk for chronic lung allograft dysfunctionCarlo J Iasella, Christopher R Ensor, Marilyn Marrari, et al.
Nature Communications|July 1, 2025
Impact of HLA evolutionary divergence and donor-recipient molecular mismatches on antibody-mediated rejection of kidney allograftsZeynep Demir, Marc Raynaud, Gillian Divard, et al.
Pageof 5